Expert consensus on personalized initiation of glucose‐lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease

Author:

Zhang Fang1,Ji Linong2,Hong Tianpei3,Guo Lixin4,Li Yan5,Zhu Zhiming6,Liu Xingbin7,Liu Fang8,Tang Lizhi1,Zhang Yuwei1,Li Juan1,Lü Qingguo1,Tong Nanwei1ORCID

Affiliation:

1. Division of Endocrinology and Metabolism Center for Diabetes and Metabolism Research West China Hospital of Sichuan University Chengdu Sichuan China

2. Department of Endocrinology and Metabolism Peking University People's Hospital, Peking University Diabetes Center Beijing China

3. Department of Endocrinology and Metabolism Peking University Third Hospital Beijing China

4. Department of Endocrinology, National Center of Gerontology Beijing Hospital Beijing China

5. Department of Endocrinology, Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China

6. Department of Hypertension and Endocrinology, Chongqing Institute of Hypertension Daping Hospital Army Medical University Chongqing China

7. Department of Cardiology West China Hospital of Sichuan University Chengdu Sichuan China

8. Department of Nephrology, Center for Diabetes and Metabolism Research West China Hospital of Sichuan University Chengdu Sichuan China

Publisher

Wiley

Subject

Health Policy,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3